Attendee search 

CLEVEXEL Pharma invests its teams' know-how to catalyze innovative drug development projects and ensure their attractiveness on the market.

We are an integrated, one-stop-shop solution for the co-development of promising new therapeutic compounds. We partner with inventors to boost the development of their product from proof-of-concept in an animal model to proof-of-concept in human. The project is then outlicensed to a pharmaceutical company for Phase III and Market Access.

Formally known as The State University of New York Health Science Center at Brooklyn—but better known to our patients and Brooklyn neighbors as SUNY Downstate Medical Center—we are older than the Brooklyn Bridge. We trace our roots back to 1860, when a school of medicine was founded at the Long Island College Hospital. The new college’s faculty revolutionized medical education in this country by bringing the teaching of medicine to the hospital bedside, thus rejecting the idea that physicians should be trained exclusively in university lecture halls.

Nobel Prize Winner in Medicine
Dr. Robert Furchgott

Today, SUNY Downstate is one of the nation’s leading urban medical centers. SUNY Downstate comprises a College of Medicine, College of Health Related Professions, College of Nursing, School of Graduate Studies, School of Public Health, and University Hospital of Brooklyn.

The quality of our education, research, and patient care programs was confirmed with the awarding of theNobel Prize in Medicine to Dr. Robert Furchgott, a member of our School of Graduate Studies faculty since 1956. Dr. Furchgott’s identification of nitric oxide as a signalling molecule important in vascular health has revolutionized care for heart, stroke, impotence, and other diseases.

As the only academic medical center in Brooklyn, we serve a large population–over 2.3 million people–and one that is among the most diverse in the world. We are also an engine of opportunity for students interested in pursuing careers in health care. Many of our students are the first in their families to attend college.

More physicians who practice medicine in New York City received their training at our College of Medicine than any other medical center in the country. Nationally, our medical school ranks seventh in the number of graduates who are now engaged in academic medicine. Here in Brooklyn, our impact is even greater. We have trained nearly half of all doctors practicing in a number of specialty areas.

Our College of Health Related Professions and College of Nursing also play a unique role in the borough and the city. We have the oldest midwifery program in the country, and we recently made history again by establishing a joint program between the two colleges that trains midwives who are not nurses. The College of Nursing is particularly proud of its role in educating minority students. Approximately three-fourths of the students are minority-group members, and many are recent immigrants.

University Hospital of Brooklyn is the borough’s only hospital located at an academic medical center. As such, it offers the most advanced and comprehensive care in Brooklyn. Many of its physicians are regularly rated among the best in New York City. Some are known throughout the world.

SUNY Downstate Medical Center enters the new century with a renewed dedication to serving the people of Brooklyn through its three-fold mission of education, research, and patient care.

Hybrigenics is developing inecalcitol, a vitamin D receptor agonist, characterized by enhanced activities against cancer cell proliferation and much reduced toxicity on blood calcium levels as compared to calcitriol, the active form of vitamin D. Therefore, inecalcitol can be given at high daily oral doses which exert cytostatic effects on tumors. 

Acute myeloid leukemia (AML) has the worse prognosis of all types of leukemias (<25% 5-year survival). Furthermore, elderly or frail AML patients cannot support standard induction chemotherapy and are eligible only to treatment with either decitabine or azacytidine, two hypo-methylating agents. The goal is to increase overall survival of these desperate patients by adding daily oral inecalcitol to hypo-methylating therapy.

Pharmaceutical products / anticancer agents / hematological malignancies / small chemical drugs /

Orphan drug status already granted for AML in US and EU / Excellent tolerance in patients / convenient daily oral dosing favoring compliance / Strong proof of principle in animal AML models

Olmix is a marine biotechnology specialist providing algae-based therapeutic solutions in CNS, oncology and immunology.

AN UNIQUE INNOVATIVE SOLUTION

Olmix group has developed specific knowledge and technologies to extract and select algal molecules of interest for animal and plant health. Some of these molecules can also be beneficial for human health and one of them has been identified as a potential antidepressant for humans.                                             

We have found in algae a new antidepressant molecule which from what we know at the moment provide beneficial effects against depression without any undesirable side effect.

KEY VALUE PROPOSITION

• Efficient Natural solution
• No side effect
• Easy to produce

TARGET MARKET SEGMENTS

• Central Nervous system             
• Antidepressant
• Other applications and compounds in oncology and immunology

TARGET PARTNERS

• Co-development partners with interest in described therapeutic areas
• Investors (Corporate funds, VC...)

Hands-free, mobile audio-video connection on smart glasses through a HIPAA exchange platform allowing the physician to communicate with the patient and nurse, permitting synchronous tele-consultations. Doctors can take pictures remotely, select areas within the photo to highlight, comment on and transfer to the nurse and patient file.

-TELEMEDICINE: AMA's solution brings healthcare expertise to patients, eliminating geographical constraints and improving quality care and patient comfort. - FINANCIAL challenges: reduces transport, hospitalisation costs and time consumption. - EMERGENCY: fast intervention, doubt removal, orientation to best-fitting hospital - E-LEARNING and mentoring: Live and personalised advice and guidance during training/interventions

Emergency 1 / Ambulances 2 / Nursing homes 3 / E-training 4

Mobility 1 / Hands-free 2 / Videoconferencing (audio - video exchanges) 3 / Efficient (cost and time saving) 4

Contacts:

• Jean-François DENIS, VP Sales
• Anne-Fleur ANDRLE, Business Development US

BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions. We offer a comprehensive test list focusing on molecular diagnostics, anatomical pathology, genetics, and women’s health. Moreover, through its GeneDx subsidiary, BioReference has an international presence in more than 50 countries around the world. 

Our client retention is unparalleled in the industry because we are much more than just the provider of quality diagnostics. We have grown primarily as a result of our differentiating business model which is both physician-centric – providing superior service and support – and clinically relevant – providing innovative and disruptive technology to improve patient outcomes. What makes us different from other labs is the added value we bring through personal attention and professional support and the effort we make to understand our clients’ needs. Our success comes from helping clinicians deliver premium services to the patients in their care – through a full menu of cost–conscious testing options and cutting edge technologies with clinically–relevant results, all in a medically and fiscally responsible manner. 

In addition, BioReference has pioneered the development of business solutions for our clients, providing data and analytics to help them operate at their fullest potential. 

The Laboratory services multiple markets through several specialized business units, each with its own dedicated sales team and highly-trained support personnel. These include women’s health, oncology, genetics and a lab division focused exclusively on the nation’s expanding Spanish-speaking populations.

Clinical Diagnostics, Oncology, Women's Health, Genetic Testing

AGuIX is a Gadolinium nanoparticle, injectable by IV, that improve MRI-guided radiation therapy, allowing personalized medicine for an optimize radiation treatment. Eliminated by the kidneys without toxicity, AGuIX allow within a single injection tumor delineation and enhancement of treatment efficacy.

Radiation therapy can generates toxicity in the organs surrounding the tumor and CT images are not specific in soft tissue areas. AGuIX enhance the tumor delineation under MRI by enhancing the contrast and boost the effect of the radiation in the tumor. AGuIX can enhance treatment efficacy and might be use to reduce the planned dose to spare the healthy organs.

1/ Radiation Oncology 2/ Contrast Agent 3/ Compagnon diagnosis

1/ Radiosensitizer 2/ MRI agent 3/ Personalized medicine / Various injection mode

Founded in 1852, The Mount Sinai Hospital is a 1,171-bed, tertiary-care teaching facility acclaimed internationally for excellence in clinical care.

U.S. News & World Report ranks The Mount Sinai Hospital among the top hospitals nationwide. Mount Sinai also ranks in several specialties and is top 10 in three of those: Geriatrics (#3), Cardiology and Heart Surgery (#7), and Gastroenterology (#8).

Welcome to the CBLS, your hub for life sciences innovation and technology-based economic development. As one of 10 New York State Centers of Excellence overseen by NYSTAR - Empire State Development's Division of Science, Technology and Innovation - we leverage our resources to drive scientific discovery and facilitate collaboration among academia, industry and the public sector.  By working with the CBLS, these researchers have access to world-class facilities, and R&D assistance, to continue to develop and patent new technologies to improve human health and expand our vibrant ecosystem.

UAlbany students choose from 120 undergraduate majors and minors and more than 125 graduate programs. Many of these programs are nationally ranked, among them criminal justice, information and technology management (Informatics), public administration, social welfare, public health andsociology. 

In every area of study, students are instructed by faculty who are world-class scholars and teachers - many actively engaged in life-enhancing research that contributes profoundly to the public good. As mentors, they provide numerous undergraduate and graduate research opportunities, inspiring students to advance their skills and aspirations.

Students take advantage of more than 600 study abroad opportunities in more than 50 countries through UAlbany and SUNY's networks. These are valuable opportunities for young scholars to enhance their education, increase independence and self-awareness, and gain international experience that prepares them for today's global marketplace.

The varied perspectives and life experiences of a student body and faculty which represent 48 states and 96 countries provide a diversity that enriches learning at UAlbany.

The excellence of a UAlbany education is recognized by many independent sources, such as the rankings published yearly by U.S. News and World Report. Its great value results from the world of opportunities that are available to students at an affordable price.

The University's location in the state capital of New York provides students with limitless opportunities for internships and public service through which they gain experience, test their skills, and prepare to launch brilliant careers. The region is also a vibrant center for culture and entertainment. Among its attractions are the New York State Museum and Library and the Times Union Center, a major Northeast entertainment and sports venue. Close by are the Berkshires, the Catskills, Saratoga, and the Adirondack Mountains, areas famed for recreational and cultural opportunities.